RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Will_A_Huang: Great resource on data thus far (or lack thereof) on experimental therapies for covid19 https://t.co/c5TIrYpFAQ
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @DrYaghoobzadeh: Tour de Force @TheLancet @TheLancetInfDis A-Z review! https://t.co/8W0ExDqwHE
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for ICU care of patients with #COVID19 from the Asian Critical Care Clinical Trials Group in @LancetRespirMed https://t.co/BPDKtvYTgl htt
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GlobalPHObserv: .@TheLancet As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges ass…
RT @GlobalPHObserv: .@TheLancet As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges ass…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @SISIACOficial: Manejo en Cuidados Intensivos de pacientes con #COVID19 publicado por @TheLancet ... Lectura recomendada!!! Link: https…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
人をトレーニングしたらいいやんって人に読んでほしい。人工呼吸器の管理ってそれだけやればいいのではなくて合併症含めた全身管理が必要になる。
Clear & focused problem/solution-style guidance on covid ICU management on @TheLancet. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/0CpgoepTGX https://t.co/p1o8Z1is1I
Clear & focused problem/solution-style guidance on covid ICU management on @TheLancet. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/0CpgoepTGX https://t.co/4vG6QOP0BN
Manejo en Cuidados Intensivos de pacientes con #COVID19 publicado por @TheLancet ... Lectura recomendada!!! Link: https://t.co/yDzfWx6TUm https://t.co/XusonkGvJU
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
、、、、🙄備えておきます
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. https://t.co/owYT6t0dpS https://t.co/scmhYcXWeU
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
Manejo de neumonia grave por COVID19 en terapia intensiva @manuelesuarez65 @AZigankoff @felixfernandezc @andres23md
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
Summary CoViD19 technical info. https://t.co/AcTiUbirvG
Review publicada ayer del manejo de pacientes críticos por COVID-19: https://t.co/KW9VyUAUMA vía @LancetRespirMed
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
of interest to all working in #intensivecare #Covid_19
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
El 2do, serie de 3 articulos del LANCET con el tratamiento actual, la fisiopatologia y posibles targets terapéuticos #COVID19 el primero: https://t.co/d3WerVVVqx
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. https://t.co/aUTbedM6LW
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think? Also a nice table at the end of the article about drugs https://t.co/vCDEueT7Q0 https://t.co/TlgWbHvAN9
RT @StephenLap: Superb overview of all aspects of #COVID19 ICU management from Singapore (by @ccmtoronto alumnus): https://t.co/tFodG4FgNC
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @robertpdickson: Does any actual data exist to support this improbable hypothesis (that immunosuppressed patients are protected from COV…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
.@TheLancet As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with this pandemic @LancetRespirMed outline such challenges & recommendations to navigate through them https://t.co/EDEIWOXw
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
RT @robertpdickson: Does any actual data exist to support this improbable hypothesis (that immunosuppressed patients are protected from COV…
RT @neuropuc: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations (open access) https://t.co/H…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @LancetRespirMed: “No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investiga…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
Und das noch: https://t.co/NOwFOtFtBN